The BAHA (bone-anchored hearing aid) is a bone conduction hearing aid with percutaneous transmission of sound vibrations to the skull. The device has been thoroughly evaluated by various implant groups. These studies showed that, in audiological terms, the BAHA is superior to conventional bone conduction devices. In comparison with air conduction devices, the results are ambiguous. However, a positive effect is found with respect to aural discharge. The most powerful BAHA can be applied to patients with a sensorineural hearing loss component of up to 60 dB HL. It was shown that bilateral BAHA application leads to binaural sound processing. Preliminary results on the application of the BAHA in patients with unilateral conductive hearing loss suggest that stereophonic hearing can be re-established. The application of the BAHA as a transcranial CROS (contralateral routing of signal) device in unilateral deafness minimizes head shadow effects.

Keywords:
Bone-anchored hearing aid, Binaural advantage, Bilateral application, Speech-in-noise test, Chronic draining ears, Aural atresia, Contralateral routing of signal, Unilateral deafness
1.
Bosman AJ, Snik AFM, van der Pouw CTM, Mylanus EAM, Cremers CWRJ: Audiometric evaluation of bilaterally fitted bone-anchored hearing aids. Audiology 2001;40:158–167.
2.
Bosman AJ, Snik AFM, Hol M, Mylanus EAM, Cremers CWRJ: Bone-anchored hearing aids in unilateral inner ear deafness. Acta Otolaryngol 2003;123:258–260.
3.
Browning GG, Gatehouse S: Estimation of the benefit of bone-anchored hearing aids. Ann Otol Rhinol Laryngol 1994;103:872–878.
4.
Carlsson PU, Håkansson BEV: The bone-anchored hearing aid: Reference quantities and functional gain. Ear Hear 1997;18:34–41.
5.
Chassin M: Bone anchored hearing aids (BAHA) and unilateral conductive losses. Hear Rev 1998;5:34–43.
6.
Dutt S: The Birmingham bone-anchored hearing aid programme. Some audiological and quality of life outcomes; thesis, Nijmegen, 2002.
7.
Håkansson B, Tjellström A, Rosenhall U: Hearing thresholds with direct bone conduction versus conventional bone conduction. Scand Audiol 1984;13:3–13.
8.
Håkansson B, Liden B, Tjellström A, Ringdahl A, Jacobsson M, Carlsson P, Erlandsson BE: Ten years of experience with the Swedish bone-anchored hearing system. Ann Otol Rhinol Laryngol Suppl 1990a;151:1–16.
9.
Håkansson B, Tjellström A, Carlsson P: Percutaneous vs. transcutaneous transducers for hearing by direct bone conduction. Otol Head Neck Surg 1990b;102:339–344.
10.
Hamann C, Manach Y, Roulleau P: La prothèse auditive à ancrage osseux BAHA. Résultats applications bilatérales. Rev Laryngol Otol Rhinol (Bord) 1991;112:297–300.
11.
Hough J, Himelick T, Johnson B: Implantable bone conduction hearing device: Audiant bone conductor. Update on our experiences. Ann Otol Rhinol Laryngol 1986;95:498–504.
12.
Jerger J, Brown D, Smith S: Effect of peripheral hearing loss on the masking level difference. Arch Otolaryngol 1984;110:290–296.
13.
Lustig LR, Arts HA, Brackmann DE, Francis HF, Molony T, Megerian CA, Moore GF, Moore KM, Morrow T, Potsic W, Rubenstein JT, Srireddy S, Syms CA, Takahashi G, Vernick D, Wackym PA, Niparko JK: Hearing rehabilitation using the BAHA, bone-anchored hearing aid; results in 40 patients. Otol Neurotol 2001;22:328–334.
14.
Macnamara M, Phillips D, Proops DW: The bone-anchored hearing aid (BAHA) in chronic suppurative otitis media (CSOM). J Laryngol Otol 1996;21(suppl):39–40.
15.
Mylanus EAM, van der Pouw CTM, Snik AFM, Cremers CWRJ: An intra-individual comparison of the BAHA and air-conduction hearing aids. Arch Otolaryngol Head Neck Surg 1998;124:271–276.
16.
Negri S, Bernath O, Häusler R: Bone conduction implants: Xomed Audiant Bone Conductor vs. BAHA. Ear Nose Throat J 1997;76:394–396.
17.
Snik AFM, Mylanus EAM, Cremers CWRJ: The bone-anchored hearing aid compared with conventional hearing aids. Audiologic results and the patients’ opinions. Otolaryngol Clin North Am 1995;28:73–83.
18.
Snik AFM, van der Pouw CTM, Beynon AJ, Cremers CWRJ: Binaural application of the bone-anchored hearing aid. Ann Otol Rhinol Laryngol 1998a;107:187–193.
19.
Snik AFM, Dreschler WA, Tange RA, Cremers CWRJ: Short- and long-term results with implantable transcutaneous and percutaneous bone-conduction devices. Arch Otolaryngol Head Neck Surg 1998b;124:265–268.
20.
Snik AFM, Mylanus EAM, Cremers CWRJ: The bone-anchored hearing aid in patients with a unilateral air-bone gap. Otol Neurotol 2002;23:61–66.
21.
Tjellström A, Håkansson B: The bone-anchored hearing aid: Design principles, indications and long-term clinical results. Otolaryngol Clin North Am 1995;28:53–72.
22.
Valente M, Valente M, Meister M, Macauley K, Vass W: Selecting and verifying hearing aid fittings for unilateral hearing loss; in Valente M (ed): Strategies for selecting and verifying hearing aid fittings. Stuttgart, Thieme, 1994, pp 228–248.
23.
Van der Pouw CTM, Carlsson P, Cremers CWRJ, Snik AFM: A new more powerful bone anchored hearing aid: First results. Scand Audiol 1998;27:179–182.
24.
Van der Pouw CTM, Snik AFM, Cremers CWRJ: The BAHA HC200/300 in comparison with conventional bone conduction hearing aids. Clin Otolaryngol 1999a;24:171–176.
25.
Van der Pouw CTM, Mylanus EAM, Cremers CWRJ: Percutaneous implants in the temporal bone for securing a bone conductor: Surgical methods and results. Ann Otol Rhinol Laryngol 1999b;108:532–537.
26.
Vaneecloo FM, Ruzza I, Hanson JN, Gerard T, Dehaussy J, Cory M, Arrouet C, Vincent C: Appareillage mono pseudo stéréophonique par BAHA dans les cophoses unilatérales: A propos de 29 patients. Rev Laryngol Otol Rhinol (Bord) 2001;122:343–350.
© 2004 S. Karger AG, Basel
2004
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.